相关实验视频
Updated: Jun 17, 2025

06:47
Microfluidics in Assessing Platelet Function
Published on: November 8, 2024
829
血小板输血增强了冠状动脉旁路移植 (CABG) 后不久的亲聚合状态,同时调节了血小板的亲炎症状态 - - 手术后1周
Javad Ahmadi1,2, Ehteramolsadat Hosseini1, Faranak Kargar3
1Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, Iran.
Journal of cellular and molecular medicine
|August 9, 2024
概括
冠状动脉旁路移植 (CABG) 患者的血小板输血显著影响血小板功能,立即增加炎症标志物,稍后增加预聚合标志物. 这些效应可以通过转化增长因子β-1 (TGF-β1) 来调节.
科学领域:
- 心血管外科心血管外科
- 血液学 血液学 血液学
- 免疫学 免疫学 免疫学
背景情况:
- 冠状动脉旁路移植 (CABG) 手术诱导炎症,可能损害血小板功能,需要输血.
- 储存的血小板是生物媒介的来源,可以影响术后的炎症和免疫反应.
研究的目的:
- 研究血小板输血对CABG患者的前聚集性,前炎性和免疫调节性标记物的影响.
- 分析CABG期间输血后血小板激活和媒介表达的时间变化.
主要方法:
- 流细胞测量用于测量20名CABG患者的血小板上P-选择素,CD40联体 (CD40L) 和PAC-1结合的P-选择素 (10例输血,10例不输血).
- 血小板内转化生长因子-β-1 (TGF-β1) 通过西式涂抹分析.
- 测量是在五个时间点进行的:手术前24小时,手术后立即,2小时,24小时和1周.
主要成果:
- 输血患者在手术后2小时显示P-选择素,CD40L和TGF-β1水平增加,与未输血患者相比 (p < 0.05).
- 在输血患者手术后24小时,PAC-1结合升高 (p < 0.05).
- 手术后一周,输血患者的血小板前炎性标志物减少,可能与TGF-β1的免疫调节作用有关.
结论:
- 血小板输血显著改变了CABG患者血小板的亲炎症,亲聚合和免疫调节状态.
- 这些影响表现为立即 (前炎性),中期 (前聚合性) 和延迟 (减轻炎症) 的后果.
- TGF-β1的免疫调节作用可能导致血小板前炎性标志物在输血后观察到的晚期减少.
相关概念视频
Formation of the Platelet Plug
5.5K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
5.5K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
502
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
502
Clot Retraction and Fibrinolysis
5.1K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
5.1K
Introduction to Hemostasis
6.8K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
6.8K
Structure and Function of Platelets
1.1K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
1.1K

